Health Care Systems

Health care systems organise the finance and delivery of health care. They vary by country, reflecting specific history, culture, and economics. To maximise coverage and efficiency they must evolve with changing demographics, needs, and technologies.

The Challenges and Economics of Drug Development in 2022
News

Forecasting the Challenges and Economics of Drug Development in 2022

9 July 2013

A new publication from the Office of Health Economics captures the views of thought leaders from around the world about the scientific and economic climate for…

HESG-June-2013
News

OHE at HESG: Informal Caregiving and Valuing End-of-Life Care

28 June 2013

The Health Economists’ Study Group (HESG) was founded in 1972 to support and promote the work of health economists. Its members are from academic, commercial, and…

Cracks through the ice on a melting glacier in Alaska
News

OHE at AES: Medicines Prices in the UK, Health Inequalities in Costa Rica

25 June 2013

OHE’s participation at the 33rd Meeting of the Spanish Health Economics Association (AES) last week reported the results of four research projects. Jorge Mestre-Ferrandiz, OHE’s Director…

Cracks through the ice on a melting glacier in Alaska
News

OHE’s Towse on Challenges in Valuing Genomic Medicines

23 May 2013

In this video, Adrian Towse discusses the challenges and importance of appropriately valuing genomic medicine. He addresses both gene therapies and “pharmacogenomics” — those medicines that…

OHE Annual Lecture
News

Contracting for Quality in the NHS is the Topic of OHE’s 20th Annual Lecture

20 May 2013

Professor Alan Maynard of the University of York, who will speak on Contracting for Quality in the NHS: Putting the Francis Report in Perspective.

Is the Link Between Health and Wealth Considered in Decision Making? Results from a Qualitative Study
News

Exploring the Link Between Health and Wealth in Government Decision Making

16 May 2013

Traditionally, decision makers both within and outside the health sector have thought of the value of health interventions primarily in terms of reduced morbidity or mortality.…

Cracks through the ice on a melting glacier in Alaska
News

OHE’s Towse on Quality Standards in the ‘New’ English NHS

29 April 2013

The 2013 conference of the Association of the British Pharmaceutical Industry (ABPI) addressed the challenges and opportunities presented by the recent changes in the NHS. Understanding…

Cracks through the ice on a melting glacier in Alaska
News

Valuing Co-Dependent Medical Technologies: Improving Methods and Processes

23 April 2013

Advances in science and technology are producing more and better means for diagnosing disease, matching patients to the best therapies, and tracking the progress of treatment.…

Prof Towse on valuing genomic medicines
News

Performance-Based Risk Sharing in Health Care: Current Status

17 April 2013

Performance-based risk sharing arrangements for prescription medicines and other treatments are attractive to payers because they promise to base what is paid for a treatment on…